As a follow up to our last event Pitch Perfect: Communicating with Investors Before AND After Funding, we’re excited to bring you Pitch Perfect II: In Action.
We’ll be showcasing four startups from the SoPE and GW community. Each will give a 10 minute pitch followed by a 5 minute Q&A to our panel of experienced venture capital and angel investors.
L
ocal incubator member and digital health company Avhana Health Inc. has been acquired by Wilmington, Del.-based digital medicine products company Amalgam Rx Inc. for an undisclosed sum.
Under terms of the purchase, which was announced Jan. 13, Avhana Health will maintain its operations in Los Angeles as a stand-alone subsidiary of Amalgam. Avhana’s chief executive, Noah Weiner, will stay on as general manager of the unit.
Image: Avhana’s Noah Weiner is focused on EHR integration.
Join the conversation with Emily Durfee, Program Manager at Healthworx, the innovation and investment arm of CareFirst. Healthworx’ Challenge focuses on improving health equity at the community level .Learn about Healthworx’ mission and vision, as Emily shares insights, answer questions and explains the intention of this terrific opportunity to connect with a very important leader in Maryland’s healthcare and innovation community.
Something of the dark horse in the race to get a COVID-19 vaccine out to the public, Novavax announced a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance, to provide 1.1 billion doses of NVX-CoV2373, its COVID-19 vaccine candidate, for the COVAX Facility. The vaccine will be manufactured and distributed around the world by Novavax and Serum Institute of India (SII). SII has an existing deal with Gavi.
Image: https://www.biospace.com
NEW YORK – Qiagen on Thursday said that it has launched a “Digital Insights Partnership” program designed to expand the market for its bioinformatics products through various third-party collaborations and deals.
The Montgomery County biotech joins a handful of other local companies to recently debut on the public markets.
Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your feedback session with BHI EIRs here: www.tinyurl.com/EIRfeedback. These take place by videoconference via Zoom. Pre-registration and forwarding of a power point deck one week before the session is required. For questions, more information, or to be added to the wait list, please contact BHI.
Please review the available slots below and click on the button to register. Thank you!
Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your feedback session with BHI EIRs here: www.tinyurl.com/EIRfeedback. These take place by videoconference via Zoom. Pre-registration and forwarding of a power point deck one week before the session is required. For questions, more information, or to be added to the wait list, please contact BHI.
Please review the available slots below and click on the button to register. Thank you!
Troy A LeMaile-Stovall, CEO and Executive Director of TEDCO, joins Rich Bendis BioTalk to discuss his background, the local ecosystem, and their vision for the future here in Maryland
Listen now via Apple http://apple.co/3tMsGQ4 , Google http://bit.ly/372QPs5 , http://spoti.fi/3tV2vXI , and TuneIn http://bit.ly/3aOuuzC.
Last month, biotechnology company United Therapeutics began tearing down the historic Elion-Hitchings building in Research Triangle Park, a Mid-Century, Brutalist structure built by the famed architect Paul Rudolph.
While the move was met with dismay from architecture lovers, the demolition could portend a large expansion on the building’s 132-acre property in the coming years.
Image: United Therapeutics currently employs more than 400 people in Research Triangle Park. UNITED THERAPEUTICS.
